IRF3 and dry eye syndrome: Whereas robust p-IRF3 was seen in WT, control KO, and IFNK-KO KCs, p-IRF3 was markedly reduced in the TMEM173-KO KCs upon CRISPR/Cas9 transfection (Figure 1E and Supplemental Figure 6).